Ocugen Q4 Earnings Call Highlights [Yahoo! Finance]
Ocugen, Inc. (OCGN)
Company Research
Source: Yahoo! Finance
expects top-line data in Q1 2027, targeting a rolling BLA start in Q3 2026 to support potential approval in 2027. Stargardt and GA programs advancing : GARDian3 is ahead of schedule with Phase II/III top-line data expected Q2 2027 and the EMA confirmed a single U.S. trial can support a European filing, while preliminary Phase II ArMaDa GA data showed a 46% reduction in lesion growth at 12 months and Phase III is planned for 2026. Higher spend but funded into late 2026 : R&D rose to $39.8M in 2025 and net loss widened to $0.23 per share, with cash runway into Q4 2026 (extendable into Q2 2027 if $30M of warrants are exercised). Interested in Ocugen, Inc.? Here are five stocks we like better. Ocugen (NASDAQ:OCGN) executives used the company's fourth-quarter and full-year 2025 earnings call to highlight late-stage progress across its modifier gene therapy pipeline, outline upcoming regulatory milestones, and review a higher year-over-year operating spend alongside an extended cash
Show less
Read more
Impact Snapshot
Event Time:
OCGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OCGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OCGN alerts
High impacting Ocugen, Inc. news events
Weekly update
A roundup of the hottest topics
OCGN
News
- Ocugen outlines 2026 BLA submission and expects three pivotal filings within three years amid leadership expansion [Seeking Alpha]Seeking Alpha
- Ocugen, Inc. (OCGN) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Ocugen, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]Yahoo! Finance
- Ocugen (OCGN) Q4 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Ocugen Provides Business Update with Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
OCGN
Earnings
- 3/4/26 - In-Line
OCGN
Sec Filings
- 3/4/26 - Form S-8
- 3/4/26 - Form 10-K
- 3/4/26 - Form 8-K
- OCGN's page on the SEC website